Correlation Between Kronos Bio and RenovoRx
Can any of the company-specific risk be diversified away by investing in both Kronos Bio and RenovoRx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kronos Bio and RenovoRx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kronos Bio and RenovoRx, you can compare the effects of market volatilities on Kronos Bio and RenovoRx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kronos Bio with a short position of RenovoRx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kronos Bio and RenovoRx.
Diversification Opportunities for Kronos Bio and RenovoRx
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Kronos and RenovoRx is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Kronos Bio and RenovoRx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RenovoRx and Kronos Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kronos Bio are associated (or correlated) with RenovoRx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RenovoRx has no effect on the direction of Kronos Bio i.e., Kronos Bio and RenovoRx go up and down completely randomly.
Pair Corralation between Kronos Bio and RenovoRx
Given the investment horizon of 90 days Kronos Bio is expected to generate 0.45 times more return on investment than RenovoRx. However, Kronos Bio is 2.2 times less risky than RenovoRx. It trades about -0.11 of its potential returns per unit of risk. RenovoRx is currently generating about -0.09 per unit of risk. If you would invest 97.00 in Kronos Bio on December 29, 2024 and sell it today you would lose (14.00) from holding Kronos Bio or give up 14.43% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Kronos Bio vs. RenovoRx
Performance |
Timeline |
Kronos Bio |
RenovoRx |
Kronos Bio and RenovoRx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Kronos Bio and RenovoRx
The main advantage of trading using opposite Kronos Bio and RenovoRx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kronos Bio position performs unexpectedly, RenovoRx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RenovoRx will offset losses from the drop in RenovoRx's long position.Kronos Bio vs. Mirum Pharmaceuticals | Kronos Bio vs. Rocket Pharmaceuticals | Kronos Bio vs. Avidity Biosciences | Kronos Bio vs. Uniqure NV |
RenovoRx vs. Adial Pharmaceuticals | RenovoRx vs. Pasithea Therapeutics Corp | RenovoRx vs. Quoin Pharmaceuticals Ltd | RenovoRx vs. Nutriband |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |